{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T00:36:56Z","timestamp":1781397416608,"version":"3.54.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,25]]},"DOI":"10.7759\/cureus.34183","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T11:03:39Z","timestamp":1674644619000},"source":"Crossref","is-referenced-by-count":13,"title":["Polycystic Ovarian Syndrome in Adolescents"],"prefix":"10.7759","author":[{"given":"Avanti","family":"Adone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darshna G","family":"Fulmali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2016.05.003","article-title":"Criteria, prevalence, and phenotypes of polycystic ovary syndrome","volume":"106","author":"Lizneva D","year":"2016","unstructured":"Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril. 2016, 106:6-15. 10.1016\/j.fertnstert.2016.05.003","journal-title":"Fertil Steril"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1159\/000479371","article-title":"An international consortium update: pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence","volume":"88","author":"Ib\u00e1\u00f1ez L","year":"2017","unstructured":"Ib\u00e1\u00f1ez L, Oberfield SE, Witchel S, et al.. An international consortium update: pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence. Horm Res Paediatr. 2017, 88:371-95. 10.1159\/000479371","journal-title":"Horm Res Paediatr"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.18544\/PEDM-24.01.0101","article-title":"Polycystic ovary syndrome (PCOS) and the accompanying disorders of glucose homeostasis among girls at the time of puberty","volume":"24","author":"Otto-Buczkowska E","year":"2018","unstructured":"Otto-Buczkowska E, Grzyb K, Jainta N. Polycystic ovary syndrome (PCOS) and the accompanying disorders of glucose homeostasis among girls at the time of puberty. Pediatr Endocrinol Diabetes Metab. 2018, 24:40-4. 10.18544\/PEDM-24.01.0101","journal-title":"Pediatr Endocrinol Diabetes Metab"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s11325-019-01835-1","article-title":"The prevalence of obstructive sleep apnoea in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"24","author":"Kahal H","year":"2020","unstructured":"Kahal H, Kyrou I, Uthman OA, et al.. The prevalence of obstructive sleep apnoea in women with polycystic ovary syndrome: a systematic review and meta-analysis. Sleep Breath. 2020, 24:339-50. 10.1007\/s11325-019-01835-1","journal-title":"Sleep Breath"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtemb.2017.04.008","article-title":"Chromium supplementation and polycystic ovary syndrome: a systematic review and meta-analysis","volume":"42","author":"Fazelian S","year":"2017","unstructured":"Fazelian S, Rouhani MH, Bank SS, Amani R. Chromium supplementation and polycystic ovary syndrome: a systematic review and meta-analysis. J Trace Elem Med Biol. 2017, 42:92-6. 10.1016\/j.jtemb.2017.04.008","journal-title":"J Trace Elem Med Biol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002698","article-title":"Polycystic ovary syndrome","volume":"132","author":"Azziz R","year":"2018","unstructured":"Azziz R. Polycystic ovary syndrome. Obstet Gynecol. 2018, 132:321-36. 10.1097\/AOG.0000000000002698","journal-title":"Obstet Gynecol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"Teede HJ","year":"2018","unstructured":"Teede HJ, Misso ML, Costello MF, et al.. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2018, 110:364-79. 10.1016\/j.fertnstert.2018.05.004","journal-title":"Fertil Steril"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-4089","article-title":"Metformin or oral contraceptives for adolescents with polycystic ovarian syndrome: a meta-analysis","volume":"137","author":"Al Khalifah RA","year":"2016","unstructured":"Al Khalifah RA, Florez ID, Dennis B, Thabane L, Bassilious E. Metformin or oral contraceptives for adolescents with polycystic ovarian syndrome: a meta-analysis. Pediatrics. 2016, 137:10.1542\/peds.2015-4089","journal-title":"Pediatrics"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/nu13061848","article-title":"Polycystic ovary syndrome in insulin-resistant adolescents with obesity: the role of nutrition therapy and food supplements as a strategy to protect fertility","volume":"13","author":"Calcaterra V","year":"2021","unstructured":"Calcaterra V, Verduci E, Cena H, et al.. Polycystic ovary syndrome in insulin-resistant adolescents with obesity: the role of nutrition therapy and food supplements as a strategy to protect fertility. Nutrients. 2021, 13:1848. 10.3390\/nu13061848","journal-title":"Nutrients"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.23736\/S0026-4946.17.04976-3","article-title":"Insulin sensitizers in adolescents with polycystic ovary syndrome","volume":"69","author":"LE TN","year":"2017","unstructured":"LE TN, Wickham EP Rd, Nestler JE. Insulin sensitizers in adolescents with polycystic ovary syndrome. Minerva Pediatr. 2017, 69:434-43. 10.23736\/S0026-4946.17.04976-3","journal-title":"Minerva Pediatr"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline","volume":"98","author":"Legro RS","year":"2013","unstructured":"Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, Welt CK. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013, 98:4565-92. 10.1210\/jc.2013-2350","journal-title":"J Clin Endocrinol Metab"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1725039","article-title":"Homeopathic treatment in patients with polycystic ovarian syndrome: a case series","volume":"110","author":"Parveen S","year":"2021","unstructured":"Parveen S, Das S. Homeopathic treatment in patients with polycystic ovarian syndrome: a case series. Homeopathy. 2021, 110:186-93. 10.1055\/s-0041-1725039","journal-title":"Homeopathy"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3928\/19382359-20210622-01","article-title":"Polycystic ovarian syndrome in adolescents: keys to diagnosis and management","volume":"50","author":"Khan L","year":"2021","unstructured":"Khan L. Polycystic ovarian syndrome in adolescents: keys to diagnosis and management. Pediatr Ann. 2021, 50:e272-5. 10.3928\/19382359-20210622-01","journal-title":"Pediatr Ann"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/nu11112711","article-title":"Dietary and physical activity behaviors in women with polycystic ovary syndrome per the new international evidence-based guideline","volume":"11","author":"Lin AW","year":"2019","unstructured":"Lin AW, Kazemi M, Jarrett BY, Vanden Brink H, Hoeger KM, Spandorfer SD, Lujan ME. Dietary and physical activity behaviors in women with polycystic ovary syndrome per the new international evidence-based guideline. Nutrients. 2019, 11:2711. 10.3390\/nu11112711","journal-title":"Nutrients"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1210\/er.2015-1104","article-title":"The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited","volume":"37","author":"Rosenfield RL","year":"2016","unstructured":"Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016, 37:467-520. 10.1210\/er.2015-1104","journal-title":"Endocr Rev"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis E","year":"2012","unstructured":"Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012, 33:981-1030. 10.1210\/er.2011-1034","journal-title":"Endocr Rev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2017.08.008","article-title":"Polycystic ovary syndrome in adolescents","volume":"48","author":"Rothenberg SS","year":"2018","unstructured":"Rothenberg SS, Beverley R, Barnard E, Baradaran-Shoraka M, Sanfilippo JS. Polycystic ovary syndrome in adolescents. Best Pract Res Clin Obstet Gynaecol. 2018, 48:103-14. 10.1016\/j.bpobgyn.2017.08.008","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21218211","article-title":"Polycystic ovary syndrome: a brain disorder characterized by eating problems originating during puberty and adolescence","volume":"21","author":"Steegers-Theunissen RP","year":"2020","unstructured":"Steegers-Theunissen RP, Wiegel RE, Jansen PW, Laven JS, Sinclair KD. Polycystic ovary syndrome: a brain disorder characterized by eating problems originating during puberty and adolescence. Int J Mol Sci. 2020, 21:8211. 10.3390\/ijms21218211","journal-title":"Int J Mol Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2016.04.007","article-title":"The role of AMH in the pathophysiology of polycystic ovarian syndrome","volume":"33","author":"Garg D","year":"2016","unstructured":"Garg D, Tal R. The role of AMH in the pathophysiology of polycystic ovarian syndrome. Reprod Biomed Online. 2016, 33:15-28. 10.1016\/j.rbmo.2016.04.007","journal-title":"Reprod Biomed Online"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1556\/OH.2013.29527","article-title":"Diagnostic difficulties of polycystic ovarian syndrome in adolescent girls (Article in Hungarian)","volume":"154","author":"S\u00e1godi L","year":"2013","unstructured":"S\u00e1godi L, Barkai L. Diagnostic difficulties of polycystic ovarian syndrome in adolescent girls (Article in Hungarian). Orv Hetil. 2013, 154:136-42. 10.1556\/OH.2013.29527","journal-title":"Orv Hetil"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/biolre\/ioab050","article-title":"Inflammation and reproductive function in women with polycystic ovary syndrome","volume":"104","author":"Velez LM","year":"2021","unstructured":"Velez LM, Seldin M, Motta AB. Inflammation and reproductive function in women with polycystic ovary syndrome. Biol Reprod. 2021, 104:1205-17. 10.1093\/biolre\/ioab050","journal-title":"Biol Reprod"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0000000000000778","article-title":"The diagnosis and treatment of PCOS in adolescents: an update","volume":"31","author":"Witchel SF","year":"2019","unstructured":"Witchel SF, Burghard AC, Tao RH, Oberfield SE. The diagnosis and treatment of PCOS in adolescents: an update. Curr Opin Pediatr. 2019, 31:562-9. 10.1097\/MOP.0000000000000778","journal-title":"Curr Opin Pediatr"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4274\/jcrpe.0014","article-title":"Abnormal uterine bleeding in adolescents","volume":"10","author":"Elmao\u011fullar\u0131 S","year":"2018","unstructured":"Elmao\u011fullar\u0131 S, Aycan Z. Abnormal uterine bleeding in adolescents. J Clin Res Pediatr Endocrinol. 2018, 10:191-7. 10.4274\/jcrpe.0014","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-016-9326-7","article-title":"Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs)","volume":"16","author":"Palioura E","year":"2015","unstructured":"Palioura E, Diamanti-Kandarakis E. Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs). Rev Endocr Metab Disord. 2015, 16:365-71. 10.1007\/s11154-016-9326-7","journal-title":"Rev Endocr Metab Disord"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-017-1047-7","article-title":"Polycystic ovary syndrome throughout a woman's life","volume":"35","author":"Bellver J","year":"2018","unstructured":"Bellver J, Rodr\u00edguez-Tabernero L, Robles A, et al.. Polycystic ovary syndrome throughout a woman's life. J Assist Reprod Genet. 2018, 35:25-39. 10.1007\/s10815-017-1047-7","journal-title":"J Assist Reprod Genet"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2010.05669.x","article-title":"Evaluation and management of adolescent amenorrhea","volume":"1205","author":"Deligeoroglou E","year":"2010","unstructured":"Deligeoroglou E, Athanasopoulos N, Tsimaris P, Dimopoulos KD, Vrachnis N, Creatsas G. Evaluation and management of adolescent amenorrhea. Ann N Y Acad Sci. 2010, 1205:23-32. 10.1111\/j.1749-6632.2010.05669.x","journal-title":"Ann N Y Acad Sci"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-018-1692-3","article-title":"Psychiatric disorders in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"62","author":"Brutocao C","year":"2018","unstructured":"Brutocao C, Zaiem F, Alsawas M, Morrow AS, Murad MH, Javed A. Psychiatric disorders in women with polycystic ovary syndrome: a systematic review and meta-analysis. Endocrine. 2018, 62:318-25. 10.1007\/s12020-018-1692-3","journal-title":"Endocrine"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/jpc.13821","article-title":"What is adolescent polycystic ovary syndrome?","volume":"54","author":"Pe\u00f1a AS","year":"2018","unstructured":"Pe\u00f1a AS, Metz M. What is adolescent polycystic ovary syndrome?. J Paediatr Child Health. 2018, 54:351-5. 10.1111\/jpc.13821","journal-title":"J Paediatr Child Health"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2019.04.006","article-title":"Polycystic ovary syndrome in adolescents","volume":"33","author":"Dabadghao P","year":"2019","unstructured":"Dabadghao P. Polycystic ovary syndrome in adolescents. Best Pract Res Clin Endocrinol Metab. 2019, 33:101272. 10.1016\/j.beem.2019.04.006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000309","article-title":"Polycystic ovary syndrome in adolescent girls","volume":"24","author":"Baldauff NH","year":"2017","unstructured":"Baldauff NH, Witchel SF. Polycystic ovary syndrome in adolescent girls. Curr Opin Endocrinol Diabetes Obes. 2017, 24:56-66. 10.1097\/MED.0000000000000309","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s10597-017-0188-6","article-title":"Predictors of depression in Iranian women with polycystic ovarian syndrome","volume":"54","author":"Mirghafourvand M","year":"2018","unstructured":"Mirghafourvand M, Charandabi SM, Lak TB, Aliasghari F. Predictors of depression in Iranian women with polycystic ovarian syndrome. Community Ment Health J. 2018, 54:1274-83. 10.1007\/s10597-017-0188-6","journal-title":"Community Ment Health J"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.808898","article-title":"Life modifications and PCOS: old story but new tales","volume":"13","author":"Gu Y","year":"2022","unstructured":"Gu Y, Zhou G, Zhou F, et al.. Life modifications and PCOS: old story but new tales. Front Endocrinol (Lausanne). 2022, 13:808898. 10.3389\/fendo.2022.808898","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2013.01.005","article-title":"Polycystic ovarian syndrome during puberty and adolescence","volume":"373","author":"Williams RM","year":"2013","unstructured":"Williams RM, Ong KK, Dunger DB. Polycystic ovarian syndrome during puberty and adolescence. Mol Cell Endocrinol. 2013, 373:61-7. 10.1016\/j.mce.2013.01.005","journal-title":"Mol Cell Endocrinol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1590\/1806-9282.20200890","article-title":"Polycystic ovary syndrome in adolescents with obesity","volume":"67","author":"Fu L","year":"2021","unstructured":"Fu L, Qu F, Pan J, Wang T, Wang F. Polycystic ovary syndrome in adolescents with obesity. Rev Assoc Med Bras (1992). 2021, 67:468-73. 10.1590\/1806-9282.20200890","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"ref35","article-title":"Relation between hyperprolactinemia and polycystic ovary syndrome (Article in German)","volume":"109","author":"H\u00e1mori M","year":"1987","unstructured":"H\u00e1mori M, Szendei G, Kov\u00e1cs I, Somos P. Relation between hyperprolactinemia and polycystic ovary syndrome (Article in German). Zentralbl Gynakol. 1987, 109:481-6.","journal-title":"Zentralbl Gynakol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1089\/met.2010.0039","article-title":"Polycystic ovary syndrome in the pediatric population","volume":"8","author":"Bremer AA","year":"2010","unstructured":"Bremer AA. Polycystic ovary syndrome in the pediatric population. Metab Syndr Relat Disord. 2010, 8:375-94. 10.1089\/met.2010.0039","journal-title":"Metab Syndr Relat Disord"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-013-9971-5","article-title":"Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility","volume":"44","author":"Panidis D","year":"2013","unstructured":"Panidis D, Tziomalos K, Papadakis E, Vosnakis C, Chatzis P, Katsikis I. Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility. Endocrine. 2013, 44:583-90. 10.1007\/s12020-013-9971-5","journal-title":"Endocrine"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12305","article-title":"The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome","volume":"80","author":"Panidis D","year":"2014","unstructured":"Panidis D, Tziomalos K, Papadakis E, Chatzis P, Kandaraki EA, Tsourdi EA, Katsikis I. The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome. Clin Endocrinol (Oxf). 2014, 80:432-8. 10.1111\/cen.12305","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2012.736557","article-title":"Diet, physical exercise and Orlistat administration increase serum anti-M\u00fcllerian hormone (AMH) levels in women with polycystic ovary syndrome (PCOS)","volume":"29","author":"Vosnakis C","year":"2013","unstructured":"Vosnakis C, Georgopoulos NA, Rousso D, et al.. Diet, physical exercise and Orlistat administration increase serum anti-M\u00fcllerian hormone (AMH) levels in women with polycystic ovary syndrome (PCOS). Gynecol Endocrinol. 2013, 29:242-5. 10.3109\/09513590.2012.736557","journal-title":"Gynecol Endocrinol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2007.04.043","article-title":"Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels","volume":"89","author":"Panidis D","year":"2008","unstructured":"Panidis D, Farmakiotis D, Rousso D, Kourtis A, Katsikis I, Krassas G. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels. Fertil Steril. 2008, 89:899-906. 10.1016\/j.fertnstert.2007.04.043","journal-title":"Fertil Steril"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.2741\/e695","article-title":"Polycystic ovary syndrome: current status and future perspective","volume":"6","author":"Barthelmess EK","year":"2014","unstructured":"Barthelmess EK, Naz RK. Polycystic ovary syndrome: current status and future perspective. Front Biosci (Elite Ed). 2014, 6:104-19. 10.2741\/e695","journal-title":"Front Biosci (Elite Ed)"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2018.04.008","article-title":"Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy","volume":"182","author":"Patel S","year":"2018","unstructured":"Patel S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol. 2018, 182:27-36. 10.1016\/j.jsbmb.2018.04.008","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-021-00517-x","article-title":"Epigenetic inheritance of polycystic ovary syndrome - challenges and opportunities for treatment","volume":"17","author":"Stener-Victorin E","year":"2021","unstructured":"Stener-Victorin E, Deng Q. Epigenetic inheritance of polycystic ovary syndrome - challenges and opportunities for treatment. Nat Rev Endocrinol. 2021, 17:521-33. 10.1038\/s41574-021-00517-x","journal-title":"Nat Rev Endocrinol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/114206-polycystic-ovarian-syndrome-in-adolescents","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:55:56Z","timestamp":1707508556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/114206-polycystic-ovarian-syndrome-in-adolescents"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,25]]},"references-count":43,"URL":"https:\/\/doi.org\/10.7759\/cureus.34183","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,25]]}}}